Enanta Pharmaceuticals (ENTA) Q4 2024 Earnings

Nov 25Confirmed
Q4 2023
Q2 2024
Q3 2024
Q4 2024
-1.58
-1.41
-1.24
-1.07

Details

Expected EPS
-1.160749
Actual EPS
-1.36
Surprise EPS
-0.2
Surprise Percent
-17.17%

Description

⁨Enanta Pharmaceuticals⁩ (⁦ENTA⁩) has reported earnings of ⁦-1.36⁩ per share for ⁦Q4 2024⁩.

0 Comments

Share your thoughts